Entecavir hydrate is the monohydrate form of entecavir. A synthetic analogue of 2′-deoxyguanosine, entecavir is a nucleoside reverse transcriptase inhibitor with selective antiviral activity against hepatitis B virus. It is grouped under the following drug class(es): Nucleosides and Reverse Transcriptase Inhibitors. Its therapeutic use is listed as anti-infectives and antivirals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Entecavir hydrate and Entecavir (USP). Its PubChem CID is 135526609.
Entecavir monohydrate
| CAS No | 209216-23-9 |
|---|---|
| Molecular Formula | C12H17N5O4 |
| Molecular Weight | 295.29 g/mol |
| Synonyms | 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1H-purin-6-one;hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Entecavir hydrate is the monohydrate form of entecavir. A synthetic analogue of 2'-deoxyguanosine, entecavir is a nucleoside reverse transcriptase inhibitor with selective antiviral activity against hepatitis B virus.
The listed CAS number is 209216-23-9.
The listed molecular formula is C12H17N5O4.
The listed molecular weight is 295.29 g/mol.
2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1H-purin-6-one;hydrate.
The source lists Entecavir hydrate and Entecavir (USP).